vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and TIDEWATER INC (TDW). Click either name above to swap in a different company.
TIDEWATER INC is the larger business by last-quarter revenue ($336.8M vs $168.4M, roughly 2.0× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -2.4%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 2.4%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Tidewater, Inc. is a publicly traded international petroleum service company headquartered in Houston, Texas, U.S. It operates a fleet of ships, primarily providing vessels and marine services to the offshore petroleum and offshore wind industries.
ESPR vs TDW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $336.8M |
| Net Profit | — | $219.9M |
| Gross Margin | — | — |
| Operating Margin | 50.6% | 19.0% |
| Net Margin | — | 65.3% |
| Revenue YoY | 143.7% | -2.4% |
| Net Profit YoY | — | 495.8% |
| EPS (diluted) | $0.32 | $4.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $336.8M | ||
| Q3 25 | $87.3M | $341.1M | ||
| Q2 25 | $82.4M | $341.4M | ||
| Q1 25 | $65.0M | $333.4M | ||
| Q4 24 | $69.1M | $345.1M | ||
| Q3 24 | $51.6M | $340.4M | ||
| Q2 24 | $73.8M | $339.2M | ||
| Q1 24 | $137.7M | $321.2M |
| Q4 25 | — | $219.9M | ||
| Q3 25 | $-31.3M | $-806.0K | ||
| Q2 25 | $-12.7M | $72.9M | ||
| Q1 25 | $-40.5M | $42.7M | ||
| Q4 24 | — | $36.9M | ||
| Q3 24 | $-29.5M | $46.4M | ||
| Q2 24 | $-61.9M | $50.4M | ||
| Q1 24 | $61.0M | $47.0M |
| Q4 25 | 50.6% | 19.0% | ||
| Q3 25 | -11.4% | 18.4% | ||
| Q2 25 | 8.6% | 23.7% | ||
| Q1 25 | -34.0% | 22.5% | ||
| Q4 24 | -6.4% | 23.6% | ||
| Q3 24 | -31.0% | 20.6% | ||
| Q2 24 | 3.5% | 23.0% | ||
| Q1 24 | 52.5% | 25.5% |
| Q4 25 | — | 65.3% | ||
| Q3 25 | -35.9% | -0.2% | ||
| Q2 25 | -15.4% | 21.4% | ||
| Q1 25 | -62.2% | 12.8% | ||
| Q4 24 | — | 10.7% | ||
| Q3 24 | -57.2% | 13.6% | ||
| Q2 24 | -83.9% | 14.8% | ||
| Q1 24 | 44.3% | 14.6% |
| Q4 25 | $0.32 | $4.37 | ||
| Q3 25 | $-0.16 | $-0.02 | ||
| Q2 25 | $-0.06 | $1.46 | ||
| Q1 25 | $-0.21 | $0.83 | ||
| Q4 24 | $-0.14 | $0.70 | ||
| Q3 24 | $-0.15 | $0.87 | ||
| Q2 24 | $-0.33 | $0.94 | ||
| Q1 24 | $0.34 | $0.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $578.8M |
| Total DebtLower is stronger | — | $670.1M |
| Stockholders' EquityBook value | $-302.0M | $1.4B |
| Total Assets | $465.9M | $2.4B |
| Debt / EquityLower = less leverage | — | 0.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $578.8M | ||
| Q3 25 | $92.4M | $428.2M | ||
| Q2 25 | $86.1M | $369.4M | ||
| Q1 25 | $114.6M | $341.8M | ||
| Q4 24 | $144.8M | $324.9M | ||
| Q3 24 | $144.7M | $280.8M | ||
| Q2 24 | $189.3M | $315.9M | ||
| Q1 24 | $226.6M | $280.9M |
| Q4 25 | — | $670.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $647.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-302.0M | $1.4B | ||
| Q3 25 | $-451.4M | $1.1B | ||
| Q2 25 | $-433.5M | $1.1B | ||
| Q1 25 | $-426.2M | $1.1B | ||
| Q4 24 | $-388.7M | $1.1B | ||
| Q3 24 | $-370.2M | $1.1B | ||
| Q2 24 | $-344.2M | $1.1B | ||
| Q1 24 | $-294.3M | $1.1B |
| Q4 25 | $465.9M | $2.4B | ||
| Q3 25 | $364.0M | $2.1B | ||
| Q2 25 | $347.1M | $2.1B | ||
| Q1 25 | $324.0M | $2.1B | ||
| Q4 24 | $343.8M | $2.1B | ||
| Q3 24 | $314.1M | $2.0B | ||
| Q2 24 | $352.3M | $2.1B | ||
| Q1 24 | $373.1M | $2.1B |
| Q4 25 | — | 0.49× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.58× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $153.0M |
| Free Cash FlowOCF − Capex | — | $147.8M |
| FCF MarginFCF / Revenue | — | 43.9% |
| Capex IntensityCapex / Revenue | 0.0% | 1.5% |
| Cash ConversionOCF / Net Profit | — | 0.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | $353.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $153.0M | ||
| Q3 25 | $-4.3M | $54.7M | ||
| Q2 25 | $-31.4M | $85.4M | ||
| Q1 25 | $-22.6M | $86.0M | ||
| Q4 24 | $-35.0M | $100.0M | ||
| Q3 24 | $-35.3M | $49.0M | ||
| Q2 24 | $-7.2M | $78.6M | ||
| Q1 24 | $53.8M | $54.8M |
| Q4 25 | — | $147.8M | ||
| Q3 25 | — | $49.6M | ||
| Q2 25 | — | $80.2M | ||
| Q1 25 | — | $75.7M | ||
| Q4 24 | — | $95.5M | ||
| Q3 24 | $-35.5M | $43.3M | ||
| Q2 24 | $-7.3M | $72.3M | ||
| Q1 24 | $53.8M | $43.8M |
| Q4 25 | — | 43.9% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 23.5% | ||
| Q1 25 | — | 22.7% | ||
| Q4 24 | — | 27.7% | ||
| Q3 24 | -68.7% | 12.7% | ||
| Q2 24 | -9.9% | 21.3% | ||
| Q1 24 | 39.0% | 13.6% |
| Q4 25 | 0.0% | 1.5% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | 0.0% | 1.5% | ||
| Q1 25 | 0.0% | 3.1% | ||
| Q4 24 | 0.0% | 1.3% | ||
| Q3 24 | 0.3% | 1.7% | ||
| Q2 24 | 0.1% | 1.9% | ||
| Q1 24 | 0.1% | 3.4% |
| Q4 25 | — | 0.70× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.17× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.71× | ||
| Q3 24 | — | 1.06× | ||
| Q2 24 | — | 1.56× | ||
| Q1 24 | 0.88× | 1.16× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
TDW
Segment breakdown not available.
